EPSILON HEALTHCARE LIMITED
ASX:EPNPharmaceuticals, Biotechnology & Life SciencesToday’s holders own 72.0% of what they think they own, once every option and right converts.
Runway under 2 quarters; options/rights overhang 39% of shares; 31% of shares in the money
EPSILON HEALTHCARE LIMITED's ordinary share count grew 12.7% between December 2024 and February 2026, reaching 389M shares. In the past 24 months, the company undertook one capital raise, a A$555K issue of convertible notes in May 2025. Options and rights on issue could convert into 151M new shares, representing 38.8% of the current share count, with 31% of these in the money based on the current share price. The nearest expiry date for these instruments is June 2028. As of June 2026, the company reported A$960K in cash, sufficient for approximately 1.5 quarters of operation. No proposed securities issues are pending.
Shares on issue — last 2 years
Cash runway
Issuance timeline
Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | On issue, per this filing | Source |
|---|---|---|---|---|
| 8 June 2026 | 3G · unquoted | EPN : ORDINARY FULLY PAID | 389.1M | Appendix 3G |
| 11 Feb 2026 | 2A · quoted issue | EPN : ORDINARY FULLY PAID | 389.1M | Appendix 2A |
| 5 Feb 2026 | 2A · quoted issue | EPN : ORDINARY FULLY PAID | 384.1M | Appendix 2A |
| 14 Sept 2025 | 2A · quoted issue | EPN : ORDINARY FULLY PAID | 379.1M | Appendix 2A |
| 10 Sept 2025 | 3H · cancellation | EPN : ORDINARY FULLY PAID | 373.1M | Appendix 3H |
Capital raises
1 cash raise in the last 24 months · 0 in the last 12 months
Forward supply
Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.
Placement capacity
How much stock a company can place without asking holders. Listing Rule 7.1 allows 15% of ordinary securities in any 12 months, and every Appendix 3B states how much of it an issue uses.
Pending proposed issues
Options & convertible securities
At $0.025 today, 119.0M securities are in the money (30.6% of shares on issue). No price up to ten times today’s switches on any more priced supply.
- Priced supply in the money at the price on the axis — the curve, and the only thing on it. Ten prices, sampled: between two of them the true figure lies between the two.
- 32.0M (21.2% of the supply above) states no exercise price at all. It cannot be called in or out of the money at any price, which is why it is hatched rather than plotted.
| Code | Security | Type | Exercise price | Expiry | On issue | Source |
|---|---|---|---|---|---|---|
| EPNAO | Options | Price-triggered | $0.020 | 24 June 2028 | 119.0M | Filing |
| — | Options | Price-triggered | — | 5 June 2029 | 32.0M | Filing |
“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column.
Director dealings
| Date | Director | Type | Shares | Options | Other | Value | Source |
|---|---|---|---|---|---|---|---|
| 3 Sept 2026 | Alan Preston Beasley | Buy on-market | 1.2M | — | — | $29k | 3Y notice |
| 3 July 2026 | Zoe Hutchings | Buy off-market | 1.5M | — | — | $30k | 3Y notice |
| 5 June 2026 | Alan Preston Beasley | Buy | 11.1M | 20.0M | — | — | 3Y notice |
Ownership
Latest announcements
Headlines link to the source PDFs on the ASX announcements platform. Data as of 12 Sept 2026.